The first CRISPR Therapeutics AG trade was made in Q2 2018. Since then Jim Simons bought shares ten more times and sold shares on twelve occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in CRISPR Therapeutics AG anymore.